These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12697343)

  • 21. Idiosyncratic cleavage and ligation activity of individual hammerhead ribozymes and core sequence variants thereof.
    Przybilski R; Hammann C
    Biol Chem; 2007 Jul; 388(7):737-41. PubMed ID: 17570826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA reprogramming and repair based on trans-splicing group I ribozymes.
    Fiskaa T; Birgisdottir AB
    N Biotechnol; 2010 Jul; 27(3):194-203. PubMed ID: 20219714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA as a catalyst: natural and designed ribozymes.
    von Ahsen U; Schroeder R
    Bioessays; 1993 May; 15(5):299-307. PubMed ID: 8343141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological and functional aspects of catalytic RNAs.
    Castanotto D; Rossi JJ; Deshler JO
    Crit Rev Eukaryot Gene Expr; 1992; 2(4):331-57. PubMed ID: 1486242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribozymes of the hepatitis delta virus: recent findings on their structure, mechanism of catalysis and possible applications.
    Ciesiolka J; Wrzesinski J; Legiewicz M; Smólska B; Dutkiewicz M
    Acta Biochim Pol; 2001; 48(2):409-18. PubMed ID: 11732611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalytic RNA, ribozyme, and its applications in synthetic biology.
    Park SV; Yang JS; Jo H; Kang B; Oh SS; Jung GY
    Biotechnol Adv; 2019 Dec; 37(8):107452. PubMed ID: 31669138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic hammerhead ribozymes as therapeutic tools to control disease genes.
    Citti L; Rainaldi G
    Curr Gene Ther; 2005 Feb; 5(1):11-24. PubMed ID: 15638708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of new hairpin ribozymes with replaced domains.
    Komatsu Y; Kanzaki I; Koizumi M; Ohtsuka E
    Nucleic Acids Symp Ser; 1995; (34):223-4. PubMed ID: 8841632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing.
    Sullenger BA; Cech TR
    Nature; 1994 Oct; 371(6498):619-22. PubMed ID: 7935797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Group II introns: elaborate ribozymes.
    Jacquier A
    Biochimie; 1996; 78(6):474-87. PubMed ID: 8915537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for important base identities in the hairpin ribozyme by in vitro selection for cleavage.
    Siwkowski A; Humphrey M; De-Young MB; Hampel A
    Biotechniques; 1998 Feb; 24(2):278-84. PubMed ID: 9494730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Group I-like ribozymes with a novel core organization perform obligate sequential hydrolytic cleavages at two processing sites.
    Einvik C; Nielsen H; Westhof E; Michel F; Johansen S
    RNA; 1998 May; 4(5):530-41. PubMed ID: 9582095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal catalytic domain of a group I self-splicing intron RNA.
    Ikawa Y; Shiraishi H; Inoue T
    Nat Struct Biol; 2000 Nov; 7(11):1032-5. PubMed ID: 11062558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Productive folding to the native state by a group II intron ribozyme.
    Swisher JF; Su LJ; Brenowitz M; Anderson VE; Pyle AM
    J Mol Biol; 2002 Jan; 315(3):297-310. PubMed ID: 11786013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribozymes: applications to functional analysis and gene discovery.
    Shiota M; Sano M; Miyagishi M; Taira K
    J Biochem; 2004 Aug; 136(2):133-47. PubMed ID: 15496583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hammerhead ribozymes: biochemical and chemical considerations.
    Goodchild J
    Curr Opin Mol Ther; 2000 Jun; 2(3):272-81. PubMed ID: 11249621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exceptionally fast self-cleavage by a Neurospora Varkud satellite ribozyme.
    Zamel R; Poon A; Jaikaran D; Andersen A; Olive J; De Abreu D; Collins RA
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1467-72. PubMed ID: 14755053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic applications of group I intron-based trans-splicing ribozymes.
    Lee CH; Han SR; Lee SW
    Wiley Interdiscip Rev RNA; 2018 May; 9(3):e1466. PubMed ID: 29383855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.